Jason Levy
Foot & Ankle Surgery · Clearwater, FLNPI 1861435414
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Stryker at 44.1% of the total.
Across 75 payments — averaging $95.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Endo USA, Inc.$3K
- Orthofix Medical, Inc.$393
- Organogenesis Inc.$300
- Medtronic$278
- MVP Orthopedics Inc$131
- plus $312 from 11 others
Across 56 payments — averaging $6561.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$367K
What the payments were for
- Travel & lodging$3,19845%
- Food & beverage$3,81753%
- Education$1672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 30 | $3,170 |
| Endo USA, Inc. | 14 | $2,598 |
| Orthofix Medical, Inc. | 6 | $393 |
| Organogenesis Inc. | 5 | $300 |
| Medtronic | 2 | $278 |
| MVP Orthopedics Inc | 2 | $131 |
| Kerecis Limited | 3 | $69 |
| Globus Medical | 1 | $38 |
| Bioventus LLC | 2 | $37 |
| Alfasigma USA, Inc. | 2 | $35 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Linvatec Corporation | 1 | $26 |
| Sandoz | 1 | $19 |
| Acumed LLC | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Merck | 1 | $13 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$912
- ALLOWRAP$367
- ANCHORAGE$318
- EASYFUSE$283
- Actishield$264
- AUGMENT INJECTABLE$264
- CITREFIX$254
- Affinity$158
- Physio-Stim Osteogenesis Stimulator$155
- AUGMENT$154
- SMART TOE$149
- ACTISHIELD CF$148
- SilverHawk$145
- VARIAX$143
- ICONIX$140
- Viaflow$140
- HawkOne$133
- PROPHECY$130
- INFINITY$129
- Physio-Stim$113
How this compares
$7,182 in reported general payments places this provider in the 70th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 218 | $1,477 |
| Pregabalin | 44 | $963 |
| Mupirocin | 128 | $936 |
| Doxycycline Hyclate | 63 | $545 |
| Meloxicam | 114 | $314 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $286 |
| Cephalexin | 12 | $231 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 21 | $172 |
| Celecoxib | 15 | $92 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Clearwater
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
- Ettore VulcanoMiami Beach$411K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.